171 related articles for article (PubMed ID: 36749231)
21. Treatment outcome of HIV-associated tuberculosis in a resource-poor setting.
Ifebunandu NA; Ukwaja KN; Obi SN
Trop Doct; 2012 Apr; 42(2):74-6. PubMed ID: 22431822
[TBL] [Abstract][Full Text] [Related]
22. Incidence and predictors of LTFU among adults with TB/HIV co-infection in two governmental hospitals, Mekelle, Ethiopia, 2009-2016: survival model approach.
Gezae KE; Abebe HT; Gebretsadik LG
BMC Infect Dis; 2019 Feb; 19(1):107. PubMed ID: 30717705
[TBL] [Abstract][Full Text] [Related]
23. T lymphocyte subpopulations and intestinal helminthes profile among tuberculosis patients co-infected with HIV before and after anti tubercular treatment at University of Gondar Hospital, Northwest Ethiopia.
Wondmagegn T; Damtie D; Genetu M; Biadgo B; Lemma M; Negash M
BMC Infect Dis; 2020 Feb; 20(1):109. PubMed ID: 32033581
[TBL] [Abstract][Full Text] [Related]
24. Improving survival with tuberculosis & HIV treatment integration: A mini-review.
Naidoo K; Rampersad S; Karim SA
Indian J Med Res; 2019 Aug; 150(2):131-138. PubMed ID: 31670268
[TBL] [Abstract][Full Text] [Related]
25. Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana.
Hafkin J; Modongo C; Newcomb C; Lowenthal E; MacGregor RR; Steenhoff AP; Friedman H; Bisson GP
Int J Tuberc Lung Dis; 2013 Mar; 17(3):348-53. PubMed ID: 23321297
[TBL] [Abstract][Full Text] [Related]
26. Incidence of tuberculosis and mycobacteriosis among HIV-infected patients--clinical and epidemiological analysis of patients from north-eastern Poland.
Łucejko M; Grzeszczuk A; Rogalska M; Flisiak R
Pneumonol Alergol Pol; 2013; 81(6):502-10. PubMed ID: 24142779
[TBL] [Abstract][Full Text] [Related]
27. Tuberculosis treatment outcome and its associated factors among people living with HIV and AIDS in Fako Division of Cameroon.
Tanue EA; Nsagha DS; Njamen TN; Assob NJC
PLoS One; 2019; 14(7):e0218800. PubMed ID: 31361755
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology of Pediatric Tuberculosis in Kenya and Risk Factors for Mortality during Treatment: A National Retrospective Cohort Study.
Onyango DO; Yuen CM; Masini E; Borgdorff MW
J Pediatr; 2018 Oct; 201():115-121. PubMed ID: 29885751
[TBL] [Abstract][Full Text] [Related]
29. Five years retrospective cohort analysis of treatment outcomes of TB-HIV patients at a PEPFAR/DOTS Centre in South Eastern Nigeria.
Babatunde OI; Christiandolus EO; Bismarck EC; Emmanuel OI; Chike AC; Gabriel EI
Afr Health Sci; 2016 Sep; 16(3):655-662. PubMed ID: 27917196
[TBL] [Abstract][Full Text] [Related]
30. Predictors of tuberculosis treatment success among HIV-TB co-infected patients attending major tuberculosis treatment sites in Abeokuta, Ogun State, Nigeria.
Akanbi K; Ajayi I; Fayemiwo S; Gidado S; Oladimeji A; Nsubuga P
Pan Afr Med J; 2019; 32(Suppl 1):7. PubMed ID: 30984328
[TBL] [Abstract][Full Text] [Related]
31. Survival model analysis of tuberculosis treatment among patients with human immunodeficiency virus coinfection.
Azeez A; Mutambayi R; Odeyemi A; Ndege J
Int J Mycobacteriol; 2019; 8(3):244-251. PubMed ID: 31512600
[TBL] [Abstract][Full Text] [Related]
32. Mortality among tuberculosis patients in the Democratic Republic of Congo.
Henegar C; Behets F; Vanden Driessche K; Tabala M; Bahati E; Bola V; Van Rie A
Int J Tuberc Lung Dis; 2012 Sep; 16(9):1199-204. PubMed ID: 22871326
[TBL] [Abstract][Full Text] [Related]
33. A retrospective cohort study of early mortality among patients with HIV/TB co-infection in Shanghai municipality.
Qi TK; Chen J; Zhang RF; Liu L; Shen YZ; Wang ZY; Sun JJ; Song W; Tang Y; Wang JR; Ling YX; Xu SB; Yang JY; Lu HZ
HIV Med; 2020 Dec; 21(11):739-746. PubMed ID: 33369033
[TBL] [Abstract][Full Text] [Related]
34. Treatment Outcome of Tuberculosis and Associated Factors among TB-HIV Co-Infected Patients at Public Hospitals of Harar Town, Eastern Ethiopia. A five-year retrospective study.
Tola A; Mishore KM; Ayele Y; Mekuria AN; Legese N
BMC Public Health; 2019 Dec; 19(1):1658. PubMed ID: 31822286
[TBL] [Abstract][Full Text] [Related]
35. Survival of HIV-infected patients after starting tuberculosis treatment: a prospective cohort study.
Maruza M; Albuquerque MF; Braga MC; Barbosa MT; Byington R; Coimbra I; Moura LV; Batista JD; Diniz GT; Miranda-Filho DB; Lacerda HR; Rodrigues LC; Ximenes RA
Int J Tuberc Lung Dis; 2012 May; 16(5):618-24. PubMed ID: 22410415
[TBL] [Abstract][Full Text] [Related]
36. Human Immunodeficiency Virus Infection-Associated Mortality during Pulmonary Tuberculosis Treatment in Six Provinces of China.
Lai YJ; Liu EY; Wang LM; Morano JP; Wang N; Khoshnood K; Zhou L; Cheng SM
Biomed Environ Sci; 2015 Jun; 28(6):421-8. PubMed ID: 26177902
[TBL] [Abstract][Full Text] [Related]
37. Clinical correlate of tuberculosis in HIV co-infected children at the University of Abuja Teaching Hospital, Gwagwalada, Nigeria.
Okechukwu AA; Okechukwu OI
Niger J Clin Pract; 2011; 14(2):206-11. PubMed ID: 21860141
[TBL] [Abstract][Full Text] [Related]
38. Survival rate and mortality risk factors among TB-HIV co-infected patients at an HIV-specialist hospital in Myanmar: A 12-year retrospective follow-up study.
Aung ZZ; Saw YM; Saw TN; Oo N; Aye HNN; Aung S; Oo HN; Cho SM; Khaing M; Kariya T; Yamamoto E; Hamajima N
Int J Infect Dis; 2019 Mar; 80():10-15. PubMed ID: 30572021
[TBL] [Abstract][Full Text] [Related]
39. Characteristics and treatment outcomes of co-infected tuberculosis patients with human immunodeficiency virus in Southeast China, 2012-2021.
Zhou Y; Li T; Lin S; Chen D; Du Y; Chen J; Chen K; Dai Z
BMC Infect Dis; 2023 Aug; 23(1):528. PubMed ID: 37563552
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting.
Gandhi NR; Andrews JR; Brust JC; Montreuil R; Weissman D; Heo M; Moll AP; Friedland GH; Shah NS
Int J Tuberc Lung Dis; 2012 Jan; 16(1):90-7. PubMed ID: 22236852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
